Methodology Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:50
Methodology Working Party
Vaccines Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:50
Vaccines Working Party
3Rs Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:45
3Rs Working Party
Quality Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:45
Quality Working Party
Haematology Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:40
Haematology Working Party
Biologics Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:30
Biologics Working Party
Biosimilar Medicinal Products Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:30
Biosimilar Medicinal Products Working Party
Cardiovascular Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:30
Cardiovascular Working Party
Central Nervous System Working Party
Submitted by Anonymous (not verified) on 4 February 2025 - 13:30
Central Nervous System Working Party
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn
Submitted by Anonymous (not verified) on 4 February 2025 - 10:53
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn